4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-003157
Director sold 3,000 shares at $285.16 ($855,480)
- Director acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
DWEK RAYMOND · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,000 | $175.43 | $526,290 | 4,750 | D |
| 2025-04-14 | Sale : show line 2 in the form 10b5-1 | −3,000 | $285.16 | $855,480 | 1,750 | D |
| Open-market sales · 3,000 sh · avg $285.16 · $855,480 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-04-14 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −3,000 | $175.43 | 2025-06-26 | 3,000 | 3,000 | D |
Loading xslF345X05/primarydocument.xml…